Hemlibra Injection, Solution
Product Images NDC 50242-922

Product Visual Gallery

This gallery contains 47 technical images submitted to the FDA as part of the official labeling for Hemlibra (NDC 50242-922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Hemlibra 01)

Illustration labeled Transfer Needle with Filter for transfer of Hemlibra (emicizumab) from vial to syringe. It shows a capped needle labeled as Needle (inside cap) and Cap.*

FDA Label Image

Figure (Hemlibra 02)

An illustration of a clear glass vial with a cap, intended for holding an injectable solution. No labels or text are visible on the vial.*

FDA Label Image

Figure (Hemlibra 03)

FDA Label Image

Figure (Hemlibra 04)

An instructional illustration showing four different sterile product components for a medical injection: two individually packaged square adhesive patches, one textured square patch, and a foam-like or cotton ball applicator pad, likely used for preparing or cleaning the injection site.*

FDA Label Image

Figure (Hemlibra 05)

An instructional diagram of a syringe showing labeled parts including the plunger at the top and the barrel below it. The drawing is a simple line illustration depicting the main components of the syringe used for injection.*

FDA Label Image

Figure (Hemlibra 06)

An instructional diagram showing a capped needle with the needle inside the cap and a labeled cap at the bottom. This illustration is likely part of a guide for using the Hemlibra (emicizumab) subcutaneous injection solution.*

FDA Label Image

Figure (Hemlibra 07)

An instructional diagram showing a safety shield and needle inside a cap for an injection device. The illustration labels the needle concealed within the cap and the adjacent safety shield used for safe handling.*

FDA Label Image

Figure (Hemlibra 08)

Packaging image of Hemlibra (emicizumab) injection, solution for subcutaneous use. The container appears to be a drug vial or cartridge, consistent with injectable medication packaging. Specific strength or volume details are not visible. The labeler is Genentech, Inc.*

FDA Label Image

Figure (Hemlibra 09)

An instructional illustration depicting a vial of medication placed on a flat surface alongside a clock showing a 15-minute countdown, indicating the medication should be allowed to stand for 15 minutes before use.*

FDA Label Image

Figure (Hemlibra 10)

An instructional diagram showing preferred subcutaneous injection sites for Hemlibra (emicizumab). The diagram highlights the abdomen, upper arm (with a note "Caregiver only"), and thigh as injection areas on a simplified human figure front view and a partial back view of the upper arms.*

FDA Label Image

Figure (Hemlibra 11)

Black and white line drawing showing hands holding a small vial and removing a rubber stopper from the vial's top. The illustration likely depicts preparation of an injection vial for use.*

FDA Label Image

Figure (Hemlibra 12)

An illustration showing a vial containing a solution next to a square alcohol prep pad, with an arrow indicating the pad is to be used on the vial top. This instructional diagram likely relates to preparation steps for a subcutaneous injection of Hemlibra (emicizumab).*

FDA Label Image

Figure (Hemlibra 13)

An instructional diagram showing a syringe assembly step for Hemlibra (emicizumab) injection. The image depicts pushing and twisting an attachment onto the syringe, with arrows indicating the direction of the movements for proper connection.*

FDA Label Image

Figure (Hemlibra 14)

An instructional illustration depicting a hand holding a syringe to administer a subcutaneous injection into a finger. The image shows an arrow indicating the injection site on the finger pad, demonstrating proper technique for injection.*

FDA Label Image

Figure (Hemlibra 15)

An instructional illustration showing a person pulling the cap off a syringe needle. The image demonstrates the proper technique for removing the needle cover before subcutaneous injection.*

FDA Label Image

Figure (Hemlibra 16)

An instructional line drawing showing a hand inserting a syringe needle into a vial. The vial contains liquid medication and is placed upright on a flat surface. The illustration depicts the step of drawing medication from the vial into the syringe.*

FDA Label Image

Figure (Hemlibra 17)

An instructional diagram showing the process of drawing solution from a vial into a syringe. The vial is inverted with an arrow indicating attachment of the syringe needle through the vial's rubber stopper to withdraw the liquid medication, depicting a typical preparation step for subcutaneous injection.*

FDA Label Image

Figure (Hemlibra 18)

An instructional illustration depicting a hand holding a vial and a syringe, showing the process of extracting medication from the vial with the syringe. The illustration is related to preparation of a subcutaneous injection.*

FDA Label Image

Figure (Hemlibra 19)

An instructional diagram showing how to draw solution from a vial using a syringe. It depicts a hand holding a vial inverted with the syringe needle inserted into the vial's rubber stopper, and the syringe plunger being pulled down to withdraw the medication. A close-up inset highlights the needle placement through the vial stopper.*

FDA Label Image

Figure (Hemlibra 20)

An instructional illustration showing a hand holding a vial and a syringe. The syringe is being drawn up with solution from the vial, with a close-up inset highlighting the syringe plunger and liquid level. The illustration is likely demonstrating the process of withdrawing Hemlibra (emicizumab) injection solution for subcutaneous administration.*

FDA Label Image

Figure (Hemlibra 21)

An instructional illustration showing two syringes filled with solution. The syringe on the left contains a properly mixed solution with a uniform appearance and a checkmark beside it, indicating correct preparation. The syringe on the right contains a solution with visible bubbles and spots, marked with an "X" to indicate improper preparation.*

FDA Label Image

Figure (Hemlibra 22)

Hemlibra 300 mg/2 mL injection, solution for subcutaneous use in a single-dose vial. The product label includes black text on a white background with purple accents and displays the Genentech, Inc. labeler name. The vial is clear with a gray cap and a purple flip-off top.*

FDA Label Image

Figure (Hemlibra 23)

An instructional illustration showing a hand holding a syringe and removing the cap from the needle, with arrows indicating the direction of the cap being pulled off. This image likely relates to the preparation or administration of a subcutaneous injection.*

FDA Label Image

Figure (Hemlibra 24)

Illustration showing recommended subcutaneous injection sites for Hemlibra (emicizumab) on the human body. The front view highlights the abdomen and thigh as injection sites, while the rear view shows the upper arm as an injection site labeled for caregiver use only.*

FDA Label Image

Figure (Hemlibra 25)

An instructional diagram showing a syringe with a cap, illustrating the action to "Twist and pull" the syringe cap off. The image uses arrows to indicate the twisting and pulling motion required to remove the cap from the syringe.*

FDA Label Image

Figure (Hemlibra 26)

An instructional diagram showing a syringe with a cap being removed by pushing and twisting. The illustration uses arrows to indicate the direction of action, demonstrating how to properly detach the syringe cap.*

FDA Label Image

Figure (Hemlibra 27)

An instructional illustration showing hands operating a syringe for subcutaneous injection. The image depicts how to rotate and remove a cap or cover from the syringe needle before use, indicated by an arrow demonstrating the movement.*

FDA Label Image

Figure (Hemlibra 28)

An instructional diagram showing hands preparing a syringe for injection, with one hand holding a vial and the other holding a syringe. There is a double-headed arrow indicating motion between the two, suggesting an action such as drawing medication from the vial.*

FDA Label Image

Figure (Hemlibra 29)

An instructional diagram showing hands preparing a syringe for injection. The image includes a close-up inset illustrating the position of the plunger at a specific measurement mark on the syringe barrel. The syringe is held vertically with an arrow indicating upward movement of the plunger.*

FDA Label Image

Figure (Hemlibra 30)

An instructional illustration showing a hand administering a Hemlibra (emicizumab) subcutaneous injection. The close-up inset diagram demonstrates the recommended needle insertion angles of 90 degrees and 45 degrees into the skin for proper injection technique.*

FDA Label Image

Figure (Hemlibra 31)

An instructional illustration showing a hand holding and pressing a syringe vertically downward, likely demonstrating subcutaneous injection technique for administering an injectable drug solution.*

FDA Label Image

Figure (Hemlibra 32)

An instructional diagram showing a hand holding a vial and inserting a syringe needle into it at an angle, indicated by an arrow pointing downward and a curved arrow demonstrating the needle's movement during preparation for injection.*

FDA Label Image

Figure (Hemlibra 33)

Illustration showing a person's hand holding a syringe at an angle with a capped needle tip near a surface, accompanied by an eye symbol with an arrow pointing to the needle, likely indicating visual inspection before use.*

FDA Label Image

Figure (Hemlibra 34)

An illustration showing a syringe with an attached needle above a small container or sharps disposal box, indicating the disposal of the syringe into the container.*

FDA Label Image

Figure (Hemlibra 35)

An instructional illustration showing the removal of a cap from a syringe, with arrows indicating the steps to pull the cap off and prepare the syringe for use.*

FDA Label Image

Figure (Hemlibra 36)

An instructional illustration showing how to prepare a syringe for injection. The image depicts a syringe with a plunger and a cap, with arrows indicating to twist and pull off the cap from the syringe tip. The text "Twist and pull" is shown below the arrows.*

FDA Label Image

Figure (Hemlibra 37)

An instructional diagram showing a syringe and cap with arrows indicating to push and twist the cap off for Hemlibra (emicizumab) injection. The image demonstrates how to prepare the syringe for subcutaneous use.*

FDA Label Image

Figure (Hemlibra 38)

An instructional illustration showing two hands handling a syringe with a needle cap. One hand holds the syringe barrel, while the other is removing or attaching the needle cap with a back-and-forth motion indicated by arrows. The image demonstrates proper syringe needle cap removal or attachment technique for subcutaneous injection.*

FDA Label Image

Figure (Hemlibra 39)

An instructional illustration demonstrating the preparation of a liquid medication by inserting a syringe needle into the rubber stopper of a vial. A hand is shown holding the syringe vertically above the vial with an arrow indicating downward insertion of the needle into the vial's top.*

FDA Label Image

Figure (Hemlibra 40)

An instructional illustration showing the assembly of a vial and a syringe. It depicts a vial positioned above a syringe with an arrow indicating how to connect or prepare the injection, suggesting the process for drawing medication from the vial into the syringe.*

FDA Label Image

Figure (Hemlibra 41)

An instructional line drawing showing a hand holding a small vial while drawing medication into a syringe with a needle inserted through the vial's rubber stopper. This image illustrates the proper technique for preparing a subcutaneous injection of Hemlibra (emicizumab) solution.*

FDA Label Image

Hemlibra 41a

An instructional illustration showing hands attaching a needle to a vial or injection device, with an enlarged circular inset detailing the needle tip connecting to the vial's rubber stopper. The diagram demonstrates preparation steps for a subcutaneous injection of Hemlibra (emicizumab) solution.*

FDA Label Image

Hemlibra 41b

FDA Label Image

Principal Display Panel (30 mg Vial Carton)

Label for Hemlibra (emicizumab-kxwh) injection, solution for subcutaneous use, at a strength of 30 mg/mL. The label instructs that it is a single-dose vial and unused portions should be discarded. It also notes to dispense the enclosed Medication Guide to each patient. The product is Rx only and labeler is Genentech.*

FDA Label Image

Principal Display Panel (60 mg Vial Carton)

Label for Hemlibra (emicizumab-kxwh) Injection, 60 mg/0.4 mL, a subcutaneous single-dose vial. The label instructs to discard unused portions and to provide the enclosed medication guide to patients. The product is labeled by Genentech, Inc. and designated for prescription use only.*

FDA Label Image

Principal Display Panel (105 mg Vial Carton)

Label for Hemlibra (emicizumab-kxwvh) Injection, 105 mg/0.7 mL, a subcutaneous single-dose vial. The label instructs to discard unused portions and dispense the enclosed Medication Guide to patients. Manufactured by Genentech, the package contains one vial for prescription use only.*

FDA Label Image

Principal Display Panel (150 mg Vial Carton)

Label for Hemlibra (emicizumab-kxwH) Injection showing 150 mg/mL strength in a single-dose vial. The label states subcutaneous use, to discard unused portions, and advises dispensing the Medication Guide. It includes the NDC 50242-923-01 and is labeled with Genentech as the manufacturer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.